PARTICS + beclomethasone dipropionate

PARTICS + beclomethasone dipropionate is a combination drug product containing the active pharmaceutical ingredient beclomethasone dipropionate and an additional component or technology referred to as "PARTICS." Beclomethasone dipropionate is a synthetic corticosteroid prodrug that, after inhalation, is rapidly converted to its active metabolite (beclomethasone 17-monopropionate), which binds with high affinity to the glucocorticoid receptor. This results in potent anti-inflammatory and immunosuppressive effects in the airways, making it effective for maintenance treatment of asthma and other chronic inflammatory respiratory conditions[1][5][10]. The precise mechanism of action involves inhibition of multiple types of inflammatory cells (such as mast cells, eosinophils, basophils, lymphocytes, macrophages, neutrophils) and suppression of various mediators involved in airway inflammation[5]. The "PARTICS" component may refer to a proprietary particle engineering or delivery technology designed to optimize lung deposition or enhance drug delivery; however, no specific details about "PARTICS" as an independent drug or excipient are available from current sources.

Brand names

PARTICS + beclomethasone dipropionate